White House slams WHO’s concern over fast-tracking COVID-19 vaccine


The White House has given a stern response to the World Health Organization’s concern over the fast-tracking COVID-19 vaccine which WHO says could endanger public safety.

Pushing back WHO’s statement from Monday, where the global health body warned about the possible dangers of rushing to a vaccine, White House spokesperson Judd Deere told, Reuters reports.

“The United States will continue to engage our international partners to ensure we defeat this virus, but we will not be constrained by multilateral organizations influenced by the corrupt World Health Organization and China,” the statement said.

The White House Statement said the President will not spare any provision to ensure the FDA’s ‘gold standards’ are met in assessing the safety, the efficacy of the vaccine.

White House’s response comes after WHO on Monday belled alarm over practices by countries trying to push the vaccine development so that one is ready for public application.

The US is one such nation, which under its Operation Wrap Speed is trying to fast-track the development of the vaccine so that it is ready for public application.

WHO’s head of the emergency program Mike Ryan said if pushed too quickly to vaccinate millions, “you may miss certain adverse effects.”

WHO’s statement came after a US Food and Drug Administration Commissioner said the body was ready to give a green signal to a COVID-19 vaccine without completing the stage III clinical trials, as long as it outcast the risks, in an interview with Financial Times.

President Trump has been critical to WHO to an extent he has formally applied to retract the US from the organization responsible for global health. The US was the biggest fund for WHO.

Trump claims the global health body is a puppet of China, and that it has sidelined with China in suppressing the alarming contagion of the virus that started to spread much before it was declared a pandemic in March.

On Tuesday, Trump also announced the US will not partake in the global vaccine pool COVAX backed by WHO and 170 other countries to make the COVID-19 vaccine widely available once possible.

The Washington Post noted Trump’s go-alone approach could endanger the economic superpower’s role in health diplomacy. A professor of global health law at Georgetown University said “America is taking a huge gamble by taking a go-it-alone strategy.” 

Trump critics define the President’s paranoid about WHO and China as a scapegoat to veil his administration’s botched response to the pandemic.

Ironically, Trump thanked Chinese President Xi Jiping in January to ensure the virus is “under control.” The US is currently the world’s worst-affected region from the virus than anywhere else.

The downside of the US decision to back out from the global scene to tackle the pandemic is apparent. If the US version of the vaccine does not turn out successful in the first go, the New Yorker magazine noted, and if the global efforts turn out a success, the US will remain back in time, while a collaborative approach by global parties will reap the benefits.